Our 2022 Year in Review
January 13, 2023
2022 was a year of tremendous growth for our team and the single ventricle research community – and we’re poised to make enormous leaps in our understanding and treatment of single ventricle heart defects.
We’re exceptionally proud of our network of dedicated investigators and clinicians that are working to deepen our understanding of single ventricle heart disease and identify pathways to curative solutions – and we’re honored to continue to support this extraordinary community.
In the past year, we expanded our Research Award Programs to target new scientific areas critical to understanding heart development. We supported Foundational Resources that capture patient history and outcomes. And, we created new mechanisms for our Scientific Community to connect, collaborate, and share ideas.
Here are just a few highlights from the past year:
- Funded 47 new studies to build resources and advance understanding of single ventricle etiology, outcomes, care, and cures.
- Committed an impressive $20.35M in funding for research and infrastructure development within the single ventricle space.
- Launched the Catalyst to Independence Award to support exceptional early career scientists.
- Convened our first in person Single Ventricle Investigator Meeting with over 170 multidisciplinary investigators dedicated to single ventricle science and care.
- Engaged with scientific journals like Nature and JCDD to galvanize the single ventricle research community.
It’s incredible to reflect on all we’ve accomplished together so far – and inspiring to look ahead to what the future holds. We’re looking forward to deepening our commitments to single ventricle communities in 2023 – and working with you all to amplify our impact in areas that need it the most.
Subscribe for Updates
We’ll keep you posted about our work across Additional Ventures.